AWH - Aspira Women's Health Inc. Operating income before deduction of amortization

The FDA-supported women's health testing ecosystem of Aspira Women's Health (AWH) ensures high customer loyalty, as evidenced by the operating income before taxes and depreciation. represents the latest value for this metric, demonstrating inflation resilience. The business relies on non-cyclical demand in oncology diagnostics, while the strategy is based on the implementation of AI analytics for the early detection of ovarian cancer.

Absolute operating profit measures the cash flow from core operations before depreciation and taxes, reflecting the ability of Aspira Women's Health (AWH) to monetize diagnostic tests through insurance programs. By analyzing the EBITDA metric, an investor separates market noise from the fundamental trend, assessing margin stability and the potential for free cash flow generation to minimize the risks of capital freeze.